Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:04:26 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:AXGN - AXOGEN INC - https://www.axogeninc.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AXGN - Q0.129.73·36.005.034.93+1.033.0822.228,06411,05434.26  35.645  34.2635.9999  9.21519:30:56Jan 2115 min RT 2¢

Recent Trades - Last 10 of 11054
Time ETExPriceChangeVolume
19:30:56Q35.621.725
18:39:02Q35.621.722
18:16:37Q35.771.872
17:37:27Q34.931.035,878
16:20:00Q34.931.0333
16:14:40Q34.931.031
16:10:04Q34.931.031
16:10:04Q34.931.031
16:10:04Q34.931.031
16:10:04Q34.931.031

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-21 23:19U:AXGNNews ReleaseAxogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
2026-01-21 16:09U:AXGNNews ReleaseAxogen Announces Proposed Public Offering of Common Stock
2026-01-12 07:00U:AXGNNews ReleaseAxogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
2025-12-17 07:00U:AXGNNews ReleaseAxogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
2025-12-03 20:01U:AXGNNews ReleaseAxogen Announces FDA Approval of Biologics License Application for AVANCE(TM) (acellular nerve allograft-arwx)
2025-11-04 07:00U:AXGNNews ReleaseAxogen, Inc. to Participate in Multiple Upcoming Investor Conferences
2025-10-29 07:00U:AXGNNews ReleaseAxogen, Inc. Reports Third Quarter 2025 Financial Results
2025-10-15 07:00U:AXGNNews ReleaseAxogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
2025-08-27 08:00U:AXGNNews ReleaseAxogen, Inc. to Participate in Multiple Upcoming Investor Conferences
2025-08-25 06:40U:AXGNNews ReleaseAxogen Provides Update on FDA Review Timeline for Avance Nerve Graft
2025-08-05 07:00U:AXGNNews ReleaseAxogen, Inc. Reports Second Quarter 2025 Financial Results
2025-07-29 16:10U:AXGNNews ReleaseAxogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
2025-07-22 16:05U:AXGNNews ReleaseAxogen, Inc. to report 2025 second quarter financial results on August 5, 2025
2025-05-28 08:00U:AXGNNews ReleaseAxogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
2025-05-08 07:05U:AXGNNews ReleaseAxogen, Inc. Reports 2025 First Quarter Financial Results
2025-05-08 07:00U:AXGNNews ReleaseAxogen Announces Chief Financial Officer Transition
2025-04-24 08:04U:AXGNNews ReleaseAxogen, Inc. to report 2025 first quarter financial results on May 8, 2025
2025-03-24 08:00U:AXGNNews ReleaseAxogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2025-02-25 07:10U:AXGNNews ReleaseAxogen, Inc. To Host Analyst & Investor Day on March 4th
2025-02-25 07:00U:AXGNNews ReleaseAxogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results